Facilitating Understanding in Informed Consent

Do you use plain language principles when developing an informed consent? Join the live webinar as our speaker discusses this guidance.

Upon completion of this continuing education program, participants should be able to:

• Be familiar with changes made to Common Rule and why FDA has issued a new draft guidance.
• Identify Key Information that might impact a trial participant’s decision on whether to participate and approaches to presenting information.
• Learn what FDA recommends on organizing and presenting information to facilitate understanding.